Press Releases

Date	Title
9/27/23	Pulse Biosciences’ First Study in a Surgical Application of Nanosecond Pulsed Field Ablation (nsPFA) Technology to be Featured in Two Poster Presentations at the American Thyroid Association Annual Meeting
9/7/23	Pulse Biosciences to Present at Gilmartin Group Emerging Growth Showcase
8/24/23	Pulse Biosciences Clarifies Details of Recent S-3 Filing
8/10/23	Pulse Biosciences Reports Business Updates and Second Quarter 2023 Financial Results
7/27/23	Pulse Biosciences Schedules Second Quarter 2023 Financial Results Conference Call for August 10, 2023
5/18/23	Pulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA™) Technology to be Featured in Several Presentations at The Heart Rhythm 2023 Annual Meeting
5/11/23	Pulse Biosciences Reports Business Updates and First Quarter 2023 Financial Results
5/10/23	Pulse Biosciences, Inc. Announces Planned Redemption of Warrants
5/3/23	Pulse Biosciences, Inc. Appoints Dr. Gan Dunnington as Chief Medical Officer
5/1/23	Pulse Biosciences Announces $65 Million Private Placement

Keyword Search